XOMETRY, INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $686.6M | $545.5M | $463.4M | $380.9M | $218.3M | $141.4M | $80.2M |
| Cost of Revenue | $417.9M | $329.9M | $285.1M | $234.9M | $161.2M | $108.1M | $65.5M |
| Gross Profit | $268.8M | $215.6M | $178.3M | $146.0M | $57.1M | $33.3M | $14.7M |
| Gross Margin | 39.1% | 39.5% | 38.5% | 38.3% | 26.2% | 23.5% | 18.4% |
| Operating Expenses | |||||||
| Research & Development | $46.8M | $39.3M | $34.5M | $31.0M | $17.8M | $12.2M | $10.6M |
| SG&A Expense | $72.3M | $65.0M | $70.9M | $58.2M | $34.9M | $12.0M | $8.0M |
| Operating Income | $-45.5M | $-56.1M | $-73.6M | $-77.1M | $-58.7M | $-29.2M | $-30.5M |
| Operating Margin | -6.6% | -10.3% | -15.9% | -20.2% | -26.9% | -20.7% | -38.1% |
| Interest Expense | $4.9M | $4.8M | $4.8M | $4.4M | $852.0K | $1.1M | $241.0K |
| Pretax Income | $-61.2M | $-50.4M | $-67.8M | $-79.0M | $-61.4M | $-31.1M | — |
| Income Tax Expense | $589.0K | $-21.0K | $-353.0K | $36.0K | — | — | — |
| Net Income | $-61.7M | $-50.4M | $-67.5M | $-79.1M | $-61.4M | $-31.1M | $-31.0M |
| Net Margin | -9.0% | -9.2% | -14.6% | -20.8% | -28.1% | -22.0% | -38.6% |
| EPS (Basic) | — | $-1.03 | $-1.41 | $-1.68 | $-2.33 | $-1.33 | $-1.22 |
| EPS (Diluted) | — | $-1.03 | $-1.41 | $-1.68 | $-2.33 | $-1.33 | $-1.22 |
| Shares Outstanding (Basic) | — | 49.1M | 47.9M | 47.2M | 26.3M | 30.0M | — |
| Shares Outstanding (Diluted) | — | 49.1M | 47.9M | 47.2M | 26.3M | 30.0M | — |
| Dividends Per Share | — | — | — | — | — | — | — |